AADI BIOSCIENCE Trademark
Trademark Overview
On Monday, October 27, 2025, a trademark application was filed for AADI BIOSCIENCE with the United States Patent and Trademark Office. The USPTO has given the AADI BIOSCIENCE trademark a serial number of 99464339. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, March 18, 2026. This trademark is owned by Aadi Bioscience, Inc.. The AADI BIOSCIENCE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Vaccine preparations; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in the treatment of diseases and disorders in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in pediatric, geriatric, emergency, family, and human preventative medicine for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Phar...
General Information
| Serial Number | 99464339 |
| Word Mark | AADI BIOSCIENCE |
| Filing Date | Monday, October 27, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, March 18, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 7, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Vaccine preparations; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in the treatment of diseases and disorders in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in pediatric, geriatric, emergency, family, and human preventative medicine for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of vascular malformations; Pharmaceutical preparations for the prevention and treatment of vascular system related diseases and disorders; Pharmaceutical preparations for use in plastic surgery; Pharmaceutical preparations for the treatment of tissue overgrowth related diseases and disorders; Pharmaceutical preparations for the treatment of vascular anomalies |
| NOT AVAILABLE | "BIOSCIENCE" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 27, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Aadi Bioscience, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Morristown, NJ 07960
US |
Trademark Events
| Event Date | Event Description |
| Monday, October 27, 2025 | NEW APPLICATION ENTERED |
| Monday, October 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 27, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 11, 2026 | ASSIGNED TO EXAMINER |
| Thursday, March 12, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 12, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 12, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 12, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 12, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
